DNMT3A c.1696_1698del ;(p.L566del)

Variant ID: 2-25467177-CCAA-C

NM_022552.4(DNMT3A):c.1696_1698del;(p.L566del)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer.

The Prostate
Markowski, Mark C MC; Shenderov, Eugene E; Eisenberger, Mario A MA; Kachhap, Sushant S; Pardoll, Drew M DM; Denmeade, Samuel R SR; Antonarakis, Emmanuel S ES
Publication Date: 2020-04

Variant appearance in text: DNMT3A: L566del
PubMed Link: 31972048
Variant Present in the following documents:
  • Main text
View BVdb publication page